Updated: 28.09.2020
PRESTIGE-AF Study: 20 Participants
Predictive Modelling of Risk Substudy: 9 Participants
Pharmacology Substudy: 1 Participant
Longitudinal Neuroimaging Substudy: 1 Participant
5 Participants:
– Site 101 Imperial College Healthcare NHS Trust- UK
3 Participants:
– Site 405 Hospital Dr Josep Trueta, Girona- Spain
2 Participants:
– Site 112 Northumbria Healthcare NHS Foundation Trust- UK
– Site 202 Essen- Germany
1 Participant:
– Site 106 Hull and East Yorkshire NHS Trust- UK
– Site 105 Mid Yorkshire Hospitals NHS Trust-UK
– Site 210 Klinikum Altenburgerland- Germany
– Site 218 Universitätsklinikum Tübingen Neurologie- German
– Site 301 Medical University Graz- Austria
– Site 411 Germans Trias I Pujol Hospital Barcelona- Spain
– Site 214 Minden- Germany
– Site 215 Leipzig- Germany
For more information about PRESTIGE-AF clinical trials and patient eligibility, contact us.
